Pharmafile Logo
Pharmafocus logo
Advanced Search
brainss

Proof-of-concept study shows non-invasive brain stimulation efficient as treatment for ADHD in children

August 2, 2023
Research and Development ADHD, Hebrew University of Jerusalem, Psychiatry, brain stimulation, clinical trial, university of surrey

Researchers from the University of Surrey, UK, and the Hebrew University of Jerusalem, Israel, have found that non-invasive brain stimulation …

News

MyMD reports statistically significant results from phase 2 trial for sarcopenia/age-related frailty

August 2, 2023
Research and Development Musculo-skeletal disorder, MyMD, clinical trial, sarcopenia

MyMD Pharmaceuticals has announced statistically significant positive topline results from a phase 2 trial of oral TNF- α inhibitor, MYMD-1 …

News

The NIH’s RECOVER initiative could lead to the first official treatment for long COVID-19

August 1, 2023
Research and Development COVID-19, Infections and infestations, NIH, clinical trials, long covid

As of 31 July 2023, The National Institutes of Health (NIH) launched the first trials of its ‘Researching COVID to …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Merck shares data from phase 3 trial for breast cancer treatment

August 1, 2023
Research and Development MSD, Merck, Oncology, breast cancer, keytruda

Merck, also known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-756 …

News

GSK’s Jemperli approved for treatment of endometrial cancer

August 1, 2023
Research and Development FDA, GSK, Jemperli, Oncology, dostarlimab, endometrial cancer

GSK has announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and …

News

Research shows neonatal stem cells could be used as treatment for Crohn’s disease

July 31, 2023
Research and Development Crohn’s disease, Gastrointestinal tract, Stem cells, gastrointestinal

Recent studies from the Ann & Robert H Lurie Children’s Hospital in Chicago have discovered that human neonatal cardiac-derived mesenchymal …

News

FDA approves a second OTC naloxone nasal spray

July 31, 2023
Medical Communications FDA, Nasal Spray, OTC, OTC Products, naloxone, opioids

The US Food and Drug Administration (FDA) has announced that it has approved RiVive, 3mg naloxone hydrochloride nasal spray for …

News
money_pills_2

Biogen to acquire Reata Pharmaceuticals

July 31, 2023
Business Services Biogen, Neurology, Reata Pharmaceuticals, acquisition

Biogen and Reata Pharmaceuticals have announced that they have entered a definitive agreement under which Biogen will acquire Reata for …

News
pills_spill

Eli Lilly shares data from two phase 3 tirzepatide studies

July 28, 2023
Research and Development Eli Lilly, Obesity, clinical trial, tirzepatide, weight loss

Eli Lilly has announced results from its two phase 3 tirezepatide studies in adult patients with obesity or who are …

News
genes

AstraZeneca’s Alexion partners with Pfizer for rare disease therapies

July 28, 2023
Research and Development Alexion, AstraZeneca, Pfizer, Rare Diseases, genomics, rare disease

Alexion, AstraZeneca’s Rare Disease division, has announced that it has entered a definitive purchase and licence agreement with Pfizer. The …

News
lungs

Hummingbird Bioscience initiates phase 1b trials for sqNSCLC

July 27, 2023
Research and Development Hummingbird Bioscience, Omico, Oncology, clinical trials, sqNSCLC

Hummingbird Bioscience has announced the initiation of two phase 1b clinical trials taking place in Australia. The trials will evaluate …

News

American Heart Association awards $2.1m to research link between migraine, strokes and CVD

July 27, 2023
Research and Development American Heart Association, Cardiology, cvd, migraine, stroke

The American Heart Association has announced that it will fund seven new scientific research studies to learn more about the …

News
medications-money-cure-tablets

Amarin gains positive opinion from Spanish Drug Pricing Committee for national reimbursement of Vazkepa in Spain

July 26, 2023
Sales and Marketing Amarin, Cardiology, Spanish Drug Pricing Committee, Vazkepa, cardiovascular

Amarin has announced that the Spanish Drug Pricing Committee has recommended the national reimbursement of Vazkepa (icosapent ethyl) in Spain …

News
Pharma pill manufacturing

Biovian announces investment in manufacturing facility in Finland

July 26, 2023
Manufacturing and Production Biovian, Pharmacy, facility, manufacturing

Biopharmaceutical based contract development and manufacturing organisation (CDMO) Biovian OY has announced an investment of over €50m to expand its …

News
pills-384846_960_720

AbbVie announces first patient dosed in phase 3 trial of upadacitinib in hidradenitis suppurativa

July 25, 2023
Research and Development AbbVie, Dermatology, HS, Rinvoq, clinical trial, upadacitinib

AbbVie has announced that the first patient has been dosed in its phase 3 Step-Up trial assessing Rinvoq (upadacitinib) for …

News
vaccinessssssssssssssssssss_1

Bavarian Nordic announces RSV vaccine did not meet all primary endpoints in phase 3 trial

July 25, 2023
Medical Communications Bavarian Nordic, Infections and infestations, RSV, Vaccine, clinical trial

Bavarian Nordic has announced that its phase 3 clinical trial of MVA-BN, its respiratory syncytial virus (RSV) vaccine candidate for …

News
Vaccine image

ViiV Healthcare gains positive CHMP opinion for cabotegravir for HIV prevention

July 24, 2023
Medical Communications CHMP, EMA, HIV, HIV/AIDS, ViiV Healthcare, cabotegravir

GSK has announced that ViiV Healthcare has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal …

News

Alnylam and Roche partner for RNAi therapeutic for treatment of hypertension

July 24, 2023
Research and Development Alnylam, Cardiology, Roche, hypertension, rnai, zilebesiran

Alnylam Pharmaceuticals has announced that it has entered a strategic agreement with Roche for the development and commercialisation of zilebesiran, …

News
stethoscope_and_background_doctor

Aevice Health gains FDA clearance for respiratory monitoring platform

July 21, 2023
Research and Development Aevice Health, Devices, FDA, respiratory monitoring

Remote respiratory monitoring solutions company Aevice Health has announced that it has received clearance from the US Food and Drug …

News

BioIVT acquires PrecisionMed for neurology and oncology research

July 21, 2023
Sales and Marketing Neurology, Oncology, neurology, oncology

BioIVT has announced that it has acquired PrecisionMed, a leading supplier of high-quality human biological material for genetics, drug discovery …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025